- call +1-201-465-4211
- email sales@mrinsights.biz
Glaucoma is a disease characterized by fluid builds up in the front part of your eye which results in damages to the eye’s optic nerve which may lead to blindness if left untreated. Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two account for greater than 50% of glaucoma cases. According to World Health Organization (WHO) estimates, Glaucoma is the second most common cause of blindness worldwide after cataract.
Scope of the Report:
This report focuses on the Glaucoma Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The market for glaucoma is increasing at an impressive rate primarily driven by the growing number of geriatrics. Older population has higher risk of developing glaucoma although other age groups may be affected. Other high risk groups include diabetics and those with a family history of glaucoma. The other market driving factors are increasing awareness, growing healthcare expenditure and screening etc.
The worldwide market for Glaucoma Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Novartis
Pfizer
Allergan
Merck
Ocular Therapeutix
Icon Bioscience
Amorphex Therapeutics
Ellex
Quantel
Lumenis
Lightmed
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prostaglandin Analogs (PGAs),
Alpha Agonist
Beta Blockers
Cholinergic Drugs
Carbonic Anhydrase Inhibitors
Others
Market Segment by Applications, can be divided into
Hospitals
Home Users
There are 15 Chapters to deeply display the global Glaucoma Treatment market.
Chapter 1, to describe Glaucoma Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Glaucoma Treatment, with sales, revenue, and price of Glaucoma Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Glaucoma Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Glaucoma Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Glaucoma Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Glaucoma Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Prostaglandin Analogs (PGAs),
1.2.2 Alpha Agonist
1.2.3 Beta Blockers
1.2.4 Cholinergic Drugs
1.2.5 Carbonic Anhydrase Inhibitors
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Home Users
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Glaucoma Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Glaucoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Glaucoma Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Glaucoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Allergan
2.3.1 Business Overview
2.3.2 Glaucoma Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Allergan Glaucoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Glaucoma Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Glaucoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Ocular Therapeutix
2.5.1 Business Overview
2.5.2 Glaucoma Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Ocular Therapeutix Glaucoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Icon Bioscience
2.6.1 Business Overview
2.6.2 Glaucoma Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Icon Bioscience Glaucoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Amorphex Therapeutics
2.7.1 Business Overview
2.7.2 Glaucoma Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Amorphex Therapeutics Glaucoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Ellex
2.8.1 Business Overview
2.8.2 Glaucoma Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ellex Glaucoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Quantel
2.9.1 Business Overview
2.9.2 Glaucoma Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Quantel Glaucoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Lumenis
2.10.1 Business Overview
2.10.2 Glaucoma Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Lumenis Glaucoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Lightmed
2.11.1 Business Overview
2.11.2 Glaucoma Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Lightmed Glaucoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Glaucoma Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Glaucoma Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Glaucoma Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Glaucoma Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 Glaucoma Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Glaucoma Treatment Market Analysis by Regions
4.1 Global Glaucoma Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Glaucoma Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global Glaucoma Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America Glaucoma Treatment Sales and Growth Rate (2013-2018)
4.3 Europe Glaucoma Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Glaucoma Treatment Sales and Growth Rate (2013-2018)
4.5 South America Glaucoma Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Glaucoma Treatment Sales and Growth Rate (2013-2018)
5 North America Glaucoma Treatment by Countries
5.1 North America Glaucoma Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Glaucoma Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America Glaucoma Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States Glaucoma Treatment Sales and Growth Rate (2013-2018)
5.3 Canada Glaucoma Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico Glaucoma Treatment Sales and Growth Rate (2013-2018)
6 Europe Glaucoma Treatment by Countries
6.1 Europe Glaucoma Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Glaucoma Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Glaucoma Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany Glaucoma Treatment Sales and Growth Rate (2013-2018)
6.3 UK Glaucoma Treatment Sales and Growth Rate (2013-2018)
6.4 France Glaucoma Treatment Sales and Growth Rate (2013-2018)
6.5 Russia Glaucoma Treatment Sales and Growth Rate (2013-2018)
6.6 Italy Glaucoma Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific Glaucoma Treatment by Countries
7.1 Asia-Pacific Glaucoma Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Glaucoma Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Glaucoma Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China Glaucoma Treatment Sales and Growth Rate (2013-2018)
7.3 Japan Glaucoma Treatment Sales and Growth Rate (2013-2018)
7.4 Korea Glaucoma Treatment Sales and Growth Rate (2013-2018)
7.5 India Glaucoma Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Glaucoma Treatment Sales and Growth Rate (2013-2018)
8 South America Glaucoma Treatment by Countries
8.1 South America Glaucoma Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Glaucoma Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America Glaucoma Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Glaucoma Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina Glaucoma Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia Glaucoma Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa Glaucoma Treatment by Countries
9.1 Middle East and Africa Glaucoma Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Glaucoma Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Glaucoma Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Glaucoma Treatment Sales and Growth Rate (2013-2018)
9.3 UAE Glaucoma Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt Glaucoma Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria Glaucoma Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa Glaucoma Treatment Sales and Growth Rate (2013-2018)
10 Global Glaucoma Treatment Market Segment by Type
10.1 Global Glaucoma Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Glaucoma Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global Glaucoma Treatment Revenue and Market Share by Type (2013-2018)
10.2 Prostaglandin Analogs (PGAs), Sales Growth and Price
10.2.1 Global Prostaglandin Analogs (PGAs), Sales Growth (2013-2018)
10.2.2 Global Prostaglandin Analogs (PGAs), Price (2013-2018)
10.3 Alpha Agonist Sales Growth and Price
10.3.1 Global Alpha Agonist Sales Growth (2013-2018)
10.3.2 Global Alpha Agonist Price (2013-2018)
10.4 Beta Blockers Sales Growth and Price
10.4.1 Global Beta Blockers Sales Growth (2013-2018)
10.4.2 Global Beta Blockers Price (2013-2018)
10.5 Cholinergic Drugs Sales Growth and Price
10.5.1 Global Cholinergic Drugs Sales Growth (2013-2018)
10.5.2 Global Cholinergic Drugs Price (2013-2018)
10.6 Carbonic Anhydrase Inhibitors Sales Growth and Price
10.6.1 Global Carbonic Anhydrase Inhibitors Sales Growth (2013-2018)
10.6.2 Global Carbonic Anhydrase Inhibitors Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Glaucoma Treatment Market Segment by Application
11.1 Global Glaucoma Treatment Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Home Users Sales Growth (2013-2018)
12 Glaucoma Treatment Market Forecast (2018-2023)
12.1 Global Glaucoma Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 Glaucoma Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America Glaucoma Treatment Market Forecast (2018-2023)
12.2.2 Europe Glaucoma Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific Glaucoma Treatment Market Forecast (2018-2023)
12.2.4 South America Glaucoma Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa Glaucoma Treatment Market Forecast (2018-2023)
12.3 Glaucoma Treatment Market Forecast by Type (2018-2023)
12.3.1 Global Glaucoma Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global Glaucoma Treatment Market Share Forecast by Type (2018-2023)
12.4 Glaucoma Treatment Market Forecast by Application (2018-2023)
12.4.1 Global Glaucoma Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global Glaucoma Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Glaucoma Treatment Picture
Table Product Specifications of Glaucoma Treatment
Figure Global Sales Market Share of Glaucoma Treatment by Types in 2017
Ta
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
